Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies
- PMID: 30363466
- PMCID: PMC6178323
- DOI: 10.21037/tau.2018.03.15
Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies
Abstract
Background: Finding incidental extraprostatic extension (EPE) or seminal vesicle invasion (SVI) by prostate cancer (PCa) is rare on standard prostate biopsy. We evaluated the clinical-pathologic features associated with EPE and SVI on multiparametric magnetic resonance imaging (MRI)/ultrasound (US) fusion-guided targeted biopsy (TB).
Methods: A retrospective review was performed from 2014-2017, selecting patients who had undergone TB. Clinical, pathologic, and radiologic features were evaluated.
Results: Five out of 333 (1.5%) patients who had PCa detected on TB had EPE and/or SVI. The average age and prostate-specific antigen (PSA) was 71 years and 17 ng/mL, respectively. The average number of cores taken on TB was 4.2. Two patients had a prior negative SB and two patients had a prior positive SB, one of which underwent radiation therapy. All patients had a PIRADSv2 suspicion score of 4 or 5. Four out of five (80%) patients underwent both SB and concurrent TB, of which 3/4 (75%) had EPE identified only on TB. One out of four (25%) patients also had both EPE and SVI, identified only on TB. One patient underwent only TB for MRI suspicion of SVI, which was pathologically confirmed on TB. On TB, one patient had Grade Group 3, two patients had Grade Group 4, and two patients had Grade Group 5 PCa. Perineural invasion (PNI) was present in 4/5 (80%) patients on TB.
Conclusions: Based on our small series, we hypothesize that MRI/US fusion TB outperforms SB in the identification of EPE and SVI. However, given the small sample size and the overall rarity of these pathologic findings on prostate biopsy, further validation is needed.
Keywords: Prostate cancer (PCa); cancer grading; cancer staging; multiparametric magnetic resonance imaging (MRI).
Conflict of interest statement
Conflicts of Interest: JW Nix and S Rais-Bahrami serve as consultants for Philips/InVivo Corp.
Similar articles
-
Diagnostic Performance of Prospectively Assigned Likert Scale Scores to Determine Extraprostatic Extension and Seminal Vesicle Invasion With Multiparametric MRI of the Prostate.AJR Am J Roentgenol. 2019 Mar;212(3):576-581. doi: 10.2214/AJR.18.20320. Epub 2018 Dec 27. AJR Am J Roentgenol. 2019. PMID: 30589381
-
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22. Eur Urol. 2016. PMID: 26112001 Free PMC article.
-
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.Eur Urol. 2020 Jun;77(6):733-741. doi: 10.1016/j.eururo.2019.09.005. Epub 2019 Sep 21. Eur Urol. 2020. PMID: 31547938
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.Urol Oncol. 2021 Oct;39(10):729.e1-729.e6. doi: 10.1016/j.urolonc.2021.02.018. Epub 2021 Mar 16. Urol Oncol. 2021. PMID: 33736975 Review.
Cited by
-
Detection of extraprostatic extension by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted combined with systemic template prostate biopsy.Diagn Pathol. 2023 Sep 11;18(1):101. doi: 10.1186/s13000-023-01386-w. Diagn Pathol. 2023. PMID: 37697349 Free PMC article.
-
PTEN and ERG detection in multiparametric magnetic resonance imaging/ultrasound fusion targeted prostate biopsy compared to systematic biopsy.Hum Pathol. 2019 Aug;90:20-26. doi: 10.1016/j.humpath.2019.04.016. Epub 2019 May 7. Hum Pathol. 2019. PMID: 31075299 Free PMC article.
-
Extraprostatic extension in prostate cancer: primer for radiologists.Abdom Radiol (NY). 2020 Dec;45(12):4040-4051. doi: 10.1007/s00261-020-02555-x. Abdom Radiol (NY). 2020. PMID: 32390076 Review.
-
Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification.Diagnostics (Basel). 2018 Nov 30;8(4):80. doi: 10.3390/diagnostics8040080. Diagnostics (Basel). 2018. PMID: 30513602 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous